01-06-2019 | Nosocomial Pneumonia | Letter to the Editor
Cost-effectiveness analysis of low versus high dose colistin in the treatment of multi-drug resistant pneumonia: a comment
Published in: International Journal of Clinical Pharmacy | Issue 3/2019
Login to get access